Home/Filings/4/0001127602-24-005071
4//SEC Filing

Clark James David 4

Accession 0001127602-24-005071

CIK 0000064803other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 5:13 PM ET

Size

15.3 KB

Accession

0001127602-24-005071

Insider Transaction Report

Form 4
Period: 2024-02-12
Clark James David
SVP, Cont & Chief Acct Officer
Transactions
  • Award

    Common Stock

    2024-02-12+2,4527,150 total
Holdings
  • Common Stock (Restricted)

    8,760
  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03Common Stock (9,050 underlying)
    9,050
  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01Common Stock (7,513 underlying)
    7,513
  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01Common Stock (24,240 underlying)
    24,240
  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01Common Stock (17,157 underlying)
    17,157
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (12,094 underlying)
    12,094
  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01Common Stock (6,756 underlying)
    6,756
  • Stock Option

    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01Common Stock (9,649 underlying)
    9,649
Footnotes (9)
  • [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024.
  • [F2]Options became exercisable in four equal annual installments beginning on 4/3/2018.
  • [F3]Options became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F4]Options became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F5]The number of shares subject to the option were calculated using a 30-day average price.
  • [F6]Options became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F7]Option became exercisable in four equal annual installments, commencing 4/1/2022.
  • [F8]Option became exercisable in four equal installments, commencing 4/1/2023.
  • [F9]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001757584

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:13 PM ET
Size
15.3 KB